{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:00:23Z","timestamp":1774418423106,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12762-5","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T10:10:36Z","timestamp":1753783836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytogenetic landscape aberrations in paediatric acute lymphoblastic leukaemia \u2014 a polish paediatric population treated according to ALL-IC BFM 2009 protocol"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-0775","authenticated-orcid":false,"given":"Monika","family":"Lejman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borys","family":"Styka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Zawitkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pastwi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Studniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Skonieczka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Zacharczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Ca\u0142ka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Haus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panasiuk","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Sadowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Przyby\u0142owicz-Chalecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Jarmu\u017c-Szymczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Malm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart\u0142omiej","family":"Drop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy R.","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"12762_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11899-016-0337-y","volume":"11","author":"LM Vrooman","year":"2016","unstructured":"Vrooman, L. M. & Silverman, L. B. Treatment of childhood acute lymphoblastic leukaemia: prognostic factors and clinical advances. Curr. Hematol. Malig Rep. 11, 385\u2013394 (2016).","journal-title":"Curr. Hematol. Malig Rep."},{"key":"12762_CR2","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1200\/JCO.22.01760","volume":"41","author":"Myriam","year":"2023","unstructured":"Myriam et al. Childhood acute lymphoblastic leukaemia: results of the randomized acute lymphoblastic leukaemia Intercontinental-Berlin-Frankfurt-Munster 2009 trial. JCO 41, 3499\u20133511. https:\/\/doi.org\/10.1200\/JCO.22.01760 (2023).","journal-title":"JCO"},{"issue":"17","key":"12762_CR3","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1182\/blood-2015-09-670729","volume":"127","author":"A M\u00f6ricke","year":"2016","unstructured":"M\u00f6ricke, A. et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood 127 (17), 2101\u20132112 (2016).","journal-title":"Blood"},{"key":"12762_CR4","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3390\/cancers13081847","volume":"13","author":"GP Contreras Yametti","year":"2021","unstructured":"Contreras Yametti, G. P. et al. Minimal residual disease in acute lymphoblastic leukaemia: current practice and future directions. Cancers (Basel). 13, 1847 (2021).","journal-title":"Cancers (Basel)"},{"issue":"9881","key":"12762_CR5","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","volume":"381","author":"H Inaba","year":"2013","unstructured":"Inaba, H., Greaves, M. & Mullighan, C. G. Acute lymphoblastic leukaemia. Lancet 381 (9881), 1943\u20131955 (2013).","journal-title":"Lancet"},{"key":"12762_CR6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758\u2013764 (2007).","journal-title":"Nature"},{"issue":"2","key":"12762_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1468-0734.2002.00069.x","volume":"6","author":"CJ Harrison","year":"2002","unstructured":"Harrison, C. J. & Foroni, L. Cytogenetics and molecular genetics of acute lymphoblastic leukaemia. Rev. Clin. Exp. Hematol. 6 (2), 91\u2013113 (2002).","journal-title":"Rev. Clin. Exp. Hematol."},{"issue":"9","key":"12762_CR8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","volume":"35","author":"I Iacobucci","year":"2017","unstructured":"Iacobucci, I. & Mullighan, C. G. Genetic basis of acute lymphoblastic leukaemia. J. Clin. Oncol. 35 (9), 975\u2013983 (2017).","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"12762_CR9","doi-asserted-by":"publisher","first-page":"e828","DOI":"10.1016\/S2352-3026(21)00304-5","volume":"8","author":"A Enshaei","year":"2021","unstructured":"Enshaei, A., Vora, A., Harrison, C. J., Moppett, J. & Moorman, A. V. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97\/99 and UKALL2003 clinical trials. Lancet Haematol. 8 (11), e828\u2013e839 (2021).","journal-title":"Lancet Haematol."},{"key":"12762_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.2532","volume":"45","author":"L Holmfeldt","year":"2013","unstructured":"Holmfeldt, L. et al. The genomic landscape of hypodiploid acute lymphoblastic leukaemia. Nat. Genet. 45, 242\u2013252 (2013).","journal-title":"Nat. Genet."},{"issue":"4","key":"12762_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2141.2005.05611.x","volume":"130","author":"LK Jones","year":"2005","unstructured":"Jones, L. K. & Saha, V. Philadelphia positive acute lymphoblastic leukaemia of childhood. Br. J. Haematol. 130 (4), 489\u2013500 (2005).","journal-title":"Br. J. Haematol."},{"key":"12762_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/leu.2011.227","volume":"26","author":"D Bhojwani","year":"2012","unstructured":"Bhojwani, D. et al. ETV6-RUNX1-positive childhood acute lymphoblastic leukaemia: improved outcome with contemporary therapy. Leukaemia 26, 265\u2013270 (2012).","journal-title":"Leukaemia"},{"issue":"35","key":"12762_CR13","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1200\/JCO.19.01692","volume":"37","author":"S Jeha","year":"2019","unstructured":"Jeha, S. et al. Improved CNS control of childhood acute lymphoblastic leukaemia without cranial irradiation: St Jude total therapy study 16. J. Clin. Oncol. 37 (35), 3377\u20133391 (2019). JCO1901692.","journal-title":"J. Clin. Oncol."},{"key":"12762_CR14","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","volume":"114","author":"BV Balgobind","year":"2009","unstructured":"Balgobind, B. V. et al. Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukaemia: results of an international retrospective study. Blood 114, 2489\u20132496 (2009).","journal-title":"Blood"},{"key":"12762_CR15","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1470-2045(09)70369-9","volume":"11","author":"T Szczepa\u0144ski","year":"2010","unstructured":"Szczepa\u0144ski, T., Harrison, C. J. & van Dongen, J. J. Genetic aberrations in paediatric acute leukaemias and implications for management of patients. Lancet Oncol. 11, 880\u2013889 (2010).","journal-title":"Lancet Oncol."},{"issue":"9","key":"12762_CR16","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3390\/ijms18091904","volume":"18","author":"D Bongiovanni","year":"2017","unstructured":"Bongiovanni, D., Saccomani, V. & Piovan, E. Aberrant signaling pathways in T-Cell acute lymphoblastic leukaemia. Int. J. Mol. Sci. 18 (9), 1904. https:\/\/doi.org\/10.3390\/ijms18091904 (2017).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"12762_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-75860-6","volume":"10","author":"J Zawitkowska","year":"2020","unstructured":"Zawitkowska, J. et al. Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukaemia. Sci. Rep. 10 (1), 1\u20139. https:\/\/doi.org\/10.1038\/s41598-020-75860-6 (2020).","journal-title":"Sci. Rep."},{"issue":"6","key":"12762_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3343\/alm.2014.34.6.413","volume":"34","author":"TSK Wan","year":"2014","unstructured":"Wan, T. S. K. Cancer cytogenetics: methodology revisited. Ann. Lab. Med. 34 (6), 413\u2013425 (2014).","journal-title":"Ann. Lab. Med."},{"key":"12762_CR19","unstructured":"ISCN (2020), An International System for Human Cytogenetic Nomenclature, red. J. McGowan-Jordan, A. Simons, M. Schmid ,\u00a0160 7\u20138\u00a0(S. Karger 2020),\u00a0"},{"issue":"3","key":"12762_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.blre.2012.01.001","volume":"26","author":"AV Moorman","year":"2012","unstructured":"Moorman, A. V. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Blood Rev. 26 (3), 123\u2013135 (2012).","journal-title":"Blood Rev."},{"issue":"07","key":"12762_CR21","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4236\/jct.2016.77056","volume":"07","author":"PSK Amare","year":"2016","unstructured":"Amare, P. S. K. et al. Cytogenetic profile in 7209 Indian patients with de Novo acute leukaemia: a single centre study from India. J. Cancer Ther. 07 (07), 530 (2016).","journal-title":"J. Cancer Ther."},{"key":"12762_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.18203\/2349-3291.ijcp20200485","volume":"7","author":"R Senthilprabhu","year":"2020","unstructured":"Senthilprabhu, R., Aruna, R. & Ravichandran, C. Cytogenetic and molecular aberrations in childhood b lineage acute lymphoblastic leukaemia. Int. J. Contemp. Pediatr. 7, 511\u2013515 (2020).","journal-title":"Int. J. Contemp. Pediatr."},{"issue":"7191","key":"12762_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06866","volume":"453","author":"CG Mullighan","year":"2008","unstructured":"Mullighan, C. G. et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453 (7191), 110\u2013114 (2008).","journal-title":"Nature"},{"issue":"1","key":"12762_CR24","first-page":"8","volume":"200","author":"E De Braekeleer","year":"2010","unstructured":"De Braekeleer, E. et al. Cytogenetics in pre-B and B-cell acute lymphoblastic leukaemia: a study of 208 patients diagnosed between 1981 and 2008. Cancer Gene Cyto. 200 (1), 8\u201315 (2010).","journal-title":"Cancer Gene Cyto"},{"key":"12762_CR25","doi-asserted-by":"publisher","unstructured":"Biondi, A. et al. Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial. Lancet Haematol. ;5(12):e641-e652.\u00a0PMID: 30501871.. https:\/\/doi.org\/10.1016\/S2352-3026(18)30173-X. (2018).","DOI":"10.1016\/S2352-3026(18)30173-X"},{"issue":"39","key":"12762_CR26","doi-asserted-by":"publisher","first-page":"66728","DOI":"10.18632\/oncotarget.19271","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Rastogi, P., Shah, B. & Zhang, L. B lymphoblastic leukaemia\/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy. Oncotarget 8 (39), 66728\u201366741. https:\/\/doi.org\/10.18632\/oncotarget.19271 (2017).","journal-title":"Oncotarget"},{"issue":"31","key":"12762_CR27","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1200\/JCO.2010.30.1325","volume":"28","author":"M Arico","year":"2010","unstructured":"Arico, M. et al. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukaemia treated between 1995 and 2005. J. Clin. Oncol. 28 (31), 4755\u20134761 (2010).","journal-title":"J. Clin. Oncol."},{"issue":"31","key":"12762_CR28","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","volume":"27","author":"KR Schultz","year":"2009","unstructured":"Schultz, K. R. et al. Improved early event-free survival with Imatinib in Philadelphia chromosome-positive acute lymphoblastic leukaemia: a children\u2019s oncology group study. J. Clin. Oncol. 27 (31), 5175\u20135181 (2009).","journal-title":"J. Clin. Oncol."},{"key":"12762_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/sj.leu.2403324","volume":"18","author":"NA Heerema","year":"2004","unstructured":"Heerema, N. A. et al. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia are nonrandom and May be associated with outcome. Leukaemia 18, 693\u2013702 (2004).","journal-title":"Leukaemia"},{"key":"12762_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2141.2005.05425.x","volume":"129","author":"A Roy","year":"2005","unstructured":"Roy, A. et al. Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the medical research Council ALL 97 trial. Br. J. Haematol. 129, 35\u201344 (2005).","journal-title":"Br. J. Haematol."},{"issue":"1","key":"12762_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11864-019-0603-z","volume":"20","author":"I Abou Dalle","year":"2019","unstructured":"Abou Dalle, I., Jabbour, E., Short, N. J. & Ravandi, F. Treatment of Philadelphia chromosome positive acute lymphoblastic leukaemia. Curr. Treat. Options Oncol. 20 (1), 4 (2019).","journal-title":"Curr. Treat. Options Oncol."},{"key":"12762_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/leu.2017.213","volume":"32","author":"C Meyer","year":"2018","unstructured":"Meyer, C. et al. The MLL recombinome of acute leukaemias in 2017. Leukaemia 32, 273\u2013284 (2018).","journal-title":"Leukaemia"},{"key":"12762_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fped.2017.00004","volume":"5","author":"AC Winters","year":"2017","unstructured":"Winters, A. C. & Bernt, K. M. MLL-rearranged leukaemias-an update on science and clinical approaches. Front. Pediatr. 5, 4 (2017).","journal-title":"Front. Pediatr."},{"key":"12762_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11899-020-00582-5","volume":"15","author":"F El Chaer","year":"2020","unstructured":"El Chaer, F., Keng, M. & Ballen, K. K. MLL-Rearranged acute lymphoblastic leukaemia. Curr. Hematol. Malig Rep. 15, 83\u201389. https:\/\/doi.org\/10.1007\/s11899-020-00582-5 (2020).","journal-title":"Curr. Hematol. Malig Rep."},{"key":"12762_CR35","doi-asserted-by":"crossref","unstructured":"Stam, R. W. et al. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukaemia. Blood. ;101(4):1270\u20136. A paper showing the relative increased resistance of MLL-r-ALL cells to corticosteroids and L-asparaginase and increased sensitivity to cytarabine chemotherapy. (2003).","DOI":"10.1182\/blood-2002-05-1600"},{"issue":"4","key":"12762_CR36","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1182\/blood-2006-07-038299","volume":"110","author":"JB Nachman","year":"2007","unstructured":"Nachman, J. B. et al. Outcome of treatment in children with hypodiploid acute lymphoblastic leukaemia. Blood 110 (4), 1112\u20131115 (2007).","journal-title":"Blood"},{"issue":"9","key":"12762_CR37","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1182\/blood-2014-03-562918","volume":"124","author":"AV Moorman","year":"2014","unstructured":"Moorman, A. V. et al. A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukaemia. Blood 124 (9), 1434\u20131444 (2014).","journal-title":"Blood"},{"issue":"2","key":"12762_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2141.2008.07417.x","volume":"144","author":"CJ Harrison","year":"2009","unstructured":"Harrison, C. J. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br. J. Haematol. 144 (2), 147\u2013156 (2009).","journal-title":"Br. J. Haematol."},{"key":"12762_CR39","doi-asserted-by":"publisher","unstructured":"Blunck, C. B. et al. CD9 predicts ETV6-RUNX1 in childhood B-cell precursor acute lymphoblastic leukaemia. Hematol. Transfus. Cell. Ther. 2019 Jul-Sep ;41(3):205\u2013211. https:\/\/doi.org\/10.1016\/j.htct.2018.11.007","DOI":"10.1016\/j.htct.2018.11.007"},{"key":"12762_CR40","doi-asserted-by":"crossref","unstructured":"Ampatzidou, M. et al. ETV6\/RUNX1-positive childhood acute lymphoblastic leukaemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis. Cancer Genet. 224\u2013225 (2018).","DOI":"10.1016\/j.cancergen.2018.03.001"},{"key":"12762_CR41","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1200\/JCO.2015.64.6364","volume":"34","author":"R Pieters","year":"2016","unstructured":"Pieters, R. et al. Successful therapy reduction and intensification for childhood acute lymphoblastic leukaemia based on minimal residual disease monitoring: study ALL10 from the Dutch childhood oncology group. J. Clin. Oncol. 34, 2591\u20132601 (2016).","journal-title":"J. Clin. Oncol."},{"key":"12762_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","volume":"11","author":"AV Moorman","year":"2010","unstructured":"Moorman, A. V. et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK medical research Council ALL97\/99 randomised trial. Lancet Oncol. 11, 429\u2013438 (2010).","journal-title":"Lancet Oncol."},{"issue":"7","key":"12762_CR43","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3109\/10428194.2011.565436","volume":"52","author":"S Mar\u00cda","year":"2011","unstructured":"Mar\u00cda, S. et al. Prognostic impact of t(1;19)\/ TCF3\u2013PBX1 in childhood acute lymphoblastic leukaemia in the context of Berlin\u2013Frankfurt\u2013M\u00fcnster-based protocols. Leuk. Lymphoma. 52 (7), 1215\u20131221. https:\/\/doi.org\/10.3109\/10428194.2011.565436 (2011).","journal-title":"Leuk. Lymphoma"},{"key":"12762_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.221","author":"D Asai","year":"2014","unstructured":"Asai, D. et al. Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukaemia patients in Japan: a collaborative study of Japan Association of Childhood Leukaemia Study (JACLS) and Children\u2019s Cancer and Leukaemia Study Group (CCLSG). Cancer Med. 3 (3), 623\u2013631. https:\/\/doi.org\/10.1002\/cam4.221 (2014).\u00a0"},{"issue":"12","key":"12762_CR45","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1038\/s41375-022-01720-z","volume":"36","author":"OA Haas","year":"2022","unstructured":"Haas, O. A. & Borkhardt, A. Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukaemia in children. Leukaemia 36 (12), 2769\u20132783. https:\/\/doi.org\/10.1038\/s41375-022-01720-z (2022).","journal-title":"Leukaemia"},{"key":"12762_CR46","doi-asserted-by":"publisher","unstructured":"Paulsson, K. et al. The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukaemia. Nat Genet. ;47(6):672-6 . PMID: 25961940.\u00a0https:\/\/doi.org\/10.1038\/ng.3301. (2015).","DOI":"10.1038\/ng.3301"},{"key":"12762_CR47","unstructured":"Mitelman, F., Johansson, B. & Mertens, F. Mitelman database of chromosome aberrations in Cancer. http:\/\/cgap.nci.nih.gov\/Chromosomes\/ (2006). Mitelman [accessed on 6 July 2006]."},{"key":"12762_CR48","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/07853890410018808","volume":"36","author":"B Johansson","year":"2004","unstructured":"Johansson, B., Mertens, F. & Mitelman, F. Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukaemia. Ann. Med. 36, 492\u2013503 (2004).","journal-title":"Ann. Med."},{"key":"12762_CR49","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2141","volume":"135","author":"J Schoumans","year":"2006","unstructured":"Schoumans, J., Johansson, B. & CorcoranMet Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2. Br. J. Haematol. 135, 492\u2013499. https:\/\/doi.org\/10.1111\/j.1365-2141 (2006).","journal-title":"Br. J. Haematol."},{"issue":"29","key":"12762_CR50","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1038\/sj.onc.1210190","volume":"26","author":"JC Strefford","year":"2007","unstructured":"Strefford, J. C. et al. Genome complexity in acute lymphoblastic leukaemia is revealed by array-based comparative genomic hybridization. Oncogene 26 (29), 4306\u20134318. https:\/\/doi.org\/10.1038\/sj.onc.1210190 (2007). Epub 2007 Jan 22. PMID: 17237825.","journal-title":"Oncogene"},{"issue":"6","key":"12762_CR51","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/humu.22057","volume":"33","author":"A Simons","year":"2012","unstructured":"Simons, A. et al. Genome-wide arrays in routine diagnostics of hematological malignancies. Hum. Mutat. 33 (6), 941\u2013948. https:\/\/doi.org\/10.1002\/humu.22057 (2012). Epub 2012 Apr 9. PMID: 22488943.","journal-title":"Hum. Mutat."},{"key":"12762_CR52","doi-asserted-by":"publisher","first-page":"1376e1389","DOI":"10.1038\/s41588-022-01159-z","volume":"54","author":"SW Brady","year":"2022","unstructured":"Brady, S. W. et al. The genomic landscape of pediatric acute lymphoblastic leukaemia. Nat. Genet. 54, 1376e1389 (2022).","journal-title":"Nat. Genet."},{"key":"12762_CR53","doi-asserted-by":"publisher","first-page":"930e942","DOI":"10.1182\/bloodadvances.2019001008","volume":"4","author":"LM Brown","year":"2020","unstructured":"Brown, L. M. et al. The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukaemia. Blood Adv. 4, 930e942 (2020).","journal-title":"Blood Adv."},{"key":"12762_CR54","doi-asserted-by":"publisher","first-page":"4093e4097","DOI":"10.1182\/bloodadvances.2021005894","volume":"6","author":"B Schmidt","year":"2022","unstructured":"Schmidt, B. et al. ALLSorts: an RNA-seq subtype classifier for B-cell acute lymphoblastic leukaemia. Blood Adv. 6, 4093e4097 (2022).","journal-title":"Blood Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12762-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12762-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12762-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:16:46Z","timestamp":1762417006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12762-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12762"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12762-5","relation":{"references":[{"id-type":"doi","id":"10.1002\/cam4.221","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article, an affiliation was ommited for Ma\u0142gorzata Jarmu\u017c-Szymczak. The correct affiliations are listed here: 10. Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland. 11. Department of Medical Informatics and Statistics with e-Health Lab, Medical University of Lublin, Lublin, Poland.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethics committee of Medical University of Lublin, Poland. The committee\u2019s reference number: KE-0254\/222\/2012.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical aproval"}}],"article-number":"27589"}}